DK129992B - Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 3,5-disubstituerede fenylætanolaminforbindelser eller terapeutisk acceptable syreadditionssalte deraf. - Google Patents
Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 3,5-disubstituerede fenylætanolaminforbindelser eller terapeutisk acceptable syreadditionssalte deraf.Info
- Publication number
- DK129992B DK129992B DK301870A DK301870A DK129992B DK 129992 B DK129992 B DK 129992B DK 301870 A DK301870 A DK 301870A DK 301870 A DK301870 A DK 301870A DK 129992 B DK129992 B DK 129992B
- Authority
- DK
- Denmark
- Prior art keywords
- disubstituted
- racemic
- preparation
- acid addition
- addition salts
- Prior art date
Links
- -1 3,5-disubstituted phenylethanolamine compounds Chemical class 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE841269A SE354279B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1969-06-13 | 1969-06-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK129992B true DK129992B (da) | 1974-12-09 |
| DK129992C DK129992C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-06-16 |
Family
ID=20274010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK301870A DK129992B (da) | 1969-06-13 | 1970-06-11 | Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 3,5-disubstituerede fenylætanolaminforbindelser eller terapeutisk acceptable syreadditionssalte deraf. |
Country Status (13)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2401450A1 (de) * | 1973-01-16 | 1974-07-18 | John James Voorhees | Pharmazeutische zusammensetzung zur linderung von hautproliferationserkrankungen |
| GB8334494D0 (en) * | 1983-12-24 | 1984-02-01 | Tanabe Seiyaku Co | Carbostyril derivatives |
| AU2013202127B2 (en) * | 2006-08-10 | 2014-06-12 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Preparation of (R,R-)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure |
| JP5302194B2 (ja) * | 2006-08-10 | 2013-10-02 | アメリカ合衆国 | （ｒ，ｒ）−フェノテロールおよび（ｒ，ｒ）−または（ｒ，ｓ）−フェノテロール類似体の調製物ならびにうっ血性心不全の治療におけるそれらの使用 |
| EP2544676B1 (en) | 2010-03-10 | 2018-09-19 | The United States of America, as represented by The Secretary, Department of Health and Human Services | The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas |
-
1969
- 1969-06-13 SE SE841269A patent/SE354279B/xx unknown
-
1970
- 1970-06-04 FI FI160370A patent/FI55648C/fi active
- 1970-06-09 GB GB2798670A patent/GB1283632A/en not_active Expired
- 1970-06-09 CA CA084,997A patent/CA959497A/en not_active Expired
- 1970-06-10 CH CH871570A patent/CH551373A/xx not_active IP Right Cessation
- 1970-06-11 BE BE751792D patent/BE751792A/xx unknown
- 1970-06-11 DK DK301870A patent/DK129992B/da unknown
- 1970-06-12 IE IE76470A patent/IE34590B1/xx unknown
- 1970-06-12 FR FR7021789A patent/FR2052969B1/fr not_active Expired
- 1970-06-12 NO NO229670A patent/NO129950B/no unknown
- 1970-06-12 NL NL7008654A patent/NL7008654A/xx not_active Application Discontinuation
- 1970-06-12 DE DE19702029000 patent/DE2029000A1/de active Pending
- 1970-06-13 JP JP5075870A patent/JPS541304B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IE34590B1 (en) | 1975-06-25 |
| CA959497A (en) | 1974-12-17 |
| FI55648C (fi) | 1979-09-10 |
| CH551373A (de) | 1974-07-15 |
| NO129950B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1974-06-17 |
| FI55648B (fi) | 1979-05-31 |
| GB1283632A (en) | 1972-08-02 |
| BE751792A (fr) | 1970-11-16 |
| DE2029000A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1970-12-23 |
| DK129992C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-06-16 |
| NL7008654A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1970-12-15 |
| SE354279B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1973-03-05 |
| FR2052969A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1971-04-16 |
| IE34590L (en) | 1970-12-13 |
| FR2052969B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1974-05-24 |
| JPS541304B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1979-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK115847B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 2,4-diamino-5-benzyl-pyrimidinderivater eller syreadditionssalte deraf. | |
| DK131029B (da) | Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-alkylaminopropaner eller syreadditionssalte deraf. | |
| DK129447B (da) | Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-sek.-alkylaminopropaner eller syreadditionssalte heraf. | |
| DK129581B (da) | Analogifremgangsmåde til fremstilling af substituerede N-allyl-2-arylamino-imidazolin-(2)-forbindelser eller syreadditionssalte deraf. | |
| DK125021B (da) | Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydro-4-phenyl-isoquinolinderivater eller syreadditionssalte deraf eller de tilsvarende optisk aktive forbindelser. | |
| DK140281B (da) | Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-cycloalkylaminopropaner eller syreadditionssalte heraf. | |
| DK136527B (da) | Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive p-alkoxyfenoxypropanolaminer eller syreadditionssalte deraf. | |
| DK122133B (da) | Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive substituerede 3-alkoxythianaphthen-2-carboxamider eller syreadditionssalte eller kvaternære ammoniumsalte deraf. | |
| DK121512B (da) | Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive substituerede 5-phenyl-6,7-benzomorphaner eller syreadditionssalte deraf. | |
| DK127599B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 2,4-diaminosubstituerede quinazolin-forbindelser eller syreadditionssalte heraf. | |
| DK137382B (da) | Analogifremgangsmåde til fremstilling af 2,2-diaryl-4-(4'-aryl-4'-hydroxy-piperidin)butyramider eller syreadditionssalte deraf. | |
| DK125639B (da) | Analogifremgangsmåde til fremstilling af racemisk eller optisk aktivt 1-(2-nitrilophenoxy)-2-hydroxy-3-ethylaminopropan eller syreadditionssalte heraf. | |
| DK139582B (da) | Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzocycloheptaisoquinolin-forbindelser eller syreadditionssalte deraf. | |
| DK119009B (da) | Analogifremgangsmåde til fremstilling af optisk aktive eller racemiske 5,9-diethyl-2'-hydroxy-2-substituerede-6,7-benzomorphan-forbindelser eller syreadditionssalte deraf. | |
| DK129992B (da) | Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 3,5-disubstituerede fenylætanolaminforbindelser eller terapeutisk acceptable syreadditionssalte deraf. | |
| DK130582B (da) | Analogifremgangsmåde til fremstilling af racemiske blandinger eller optisk aktive isomere af 5-cyclohexyl-1-indancarboxylsyreforbindelser. | |
| DK131988B (da) | Analogifremgangsmåde til fremstilling af optisk aktive eller racemiske 1-aryloxy-2-hydroxy-3-isopropylamino-propaner eller syreadditionssalte heraf. | |
| DK129235B (da) | Fremgangsmåde til fremstilling af racemiske eller optisk aktive quinolinderivater eller syreadditionssalte deraf. | |
| DK130958B (da) | Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropaner eller fysiologisk tålelige syreadditionssalte heraf. | |
| DK127424B (da) | Analogifremgangsmåde til fremstilling af 4-aryl-1-(4,4-diarylbutyl)-4-hydroxypiperidiner eller syreadditionssalte deraf. | |
| DK129699B (da) | Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 9,10-dihydro-9,10-ethano-anthracener eller syreadditionssalte deraf. | |
| DK122128B (da) | Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 2-(4,4'-dihalo)-benzhydryl-3-quinuclidinoler eller syreadditionssalte deraf. | |
| DK129718B (da) | Analogifremgangsmåde til fremstilling af tiazolino-pyrimidin-5-oner eller deres syreadditionssalte eller de tilsvarende optisk aktive forbindelser. | |
| DK131470B (da) | Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive thiazolino-pyrimidin-5-on derivater eller syreadditionssalte deraf. | |
| DK118613B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 3,4-dihydroxyphenyl-alkanolaminer eller syreadditionssalte heraf. |